R&D Systems™ Recombinant Human S100A7 Protein

Catalog No.	Quantity
90-85S-A050	50 μg

Catalog No. 90-85S-A050 Supplier R&D Systems™ Supplier No. 9085SA050

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

The Recombinant Human S100A7 Protein is derived from E. coli. The Recombinant Human S100A7 Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: AAH34687
• For Use With (Application): Bioactivity
• Gene ID (Entrez): 6278
• Molecular Weight (g/mol): Observed M.W.: 11kDa, reducing conditions, Theoretical M.W.: 11kDa
• Quantity: 50 μg
• Source: E. coli-derived human S100A7 protein Ser2-Gln101 with an N-terminal Met
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU per 1μg of the protein by the LAL method.
• Gene Alias: HID 5, HID5, HID-5, protein S100-A7, PSOR1, Psoriasin, psoriasin 1, S100 calcium binding protein A7, S100 calcium binding protein A7 (psoriasin 1), S100 calcium-binding protein A7, S100 calcium-binding protein A7 (psoriasin 1), S100A7c
• Common Name: S100A7/Psoriasin
• Gene Symbol: S100A7
• Biological Activity: Measured by its ability to induce IL-8 secretion in A431 human epithelial carcinoma cells. The ED50 for this effect is typically 2-10μg/mL.
• Conjugate: Unconjugated
• Species: Human
• Recombinant: Recombinant
• Expression System: E. coli-derived Ser2-Gln101 with an N-terminal Met
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining